154 related articles for article (PubMed ID: 19834714)
1. Arsenic exposure predicts bladder cancer survival in a US population.
Kwong RC; Karagas MR; Kelsey KT; Mason RA; Tanyos SA; Schned AR; Marsit CJ; Andrew AS
World J Urol; 2010 Aug; 28(4):487-92. PubMed ID: 19834714
[TBL] [Abstract][Full Text] [Related]
2. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
3. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water.
Cottingham KL; Karimi R; Gruber JF; Zens MS; Sayarath V; Folt CL; Punshon T; Morris JS; Karagas MR
Nutr J; 2013 Nov; 12():149. PubMed ID: 24237880
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.
Karagas MR; Stukel TA; Morris JS; Tosteson TD; Weiss JE; Spencer SK; Greenberg ER
Am J Epidemiol; 2001 Mar; 153(6):559-65. PubMed ID: 11257063
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
Karagas MR; Stukel TA; Tosteson TD
Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
[TBL] [Abstract][Full Text] [Related]
6. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A
Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466
[TBL] [Abstract][Full Text] [Related]
7. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
Karagas MR; Tosteson TD; Blum J; Morris JS; Baron JA; Klaue B
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1047-50. PubMed ID: 9703491
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
Slotnick MJ; Meliker JR; Nriagu JO
J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
[TBL] [Abstract][Full Text] [Related]
9. Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
Baris D; Waddell R; Beane Freeman LE; Schwenn M; Colt JS; Ayotte JD; Ward MH; Nuckols J; Schned A; Jackson B; Clerkin C; Rothman N; Moore LE; Taylor A; Robinson G; Hosain GM; Armenti KR; McCoy R; Samanic C; Hoover RN; Fraumeni JF; Johnson A; Karagas MR; Silverman DT
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27140955
[TBL] [Abstract][Full Text] [Related]
10. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.
Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO
Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543
[TBL] [Abstract][Full Text] [Related]
11. Associations between toenail arsenic concentration and dietary factors in a New Hampshire population.
Gruber JF; Karagas MR; Gilbert-Diamond D; Bagley PJ; Zens MS; Sayarath V; Punshon T; Morris JS; Cottingham KL
Nutr J; 2012 Jun; 11():45. PubMed ID: 22747713
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer in a U.S. population with low to moderate arsenic exposure.
Heck JE; Andrew AS; Onega T; Rigas JR; Jackson BP; Karagas MR; Duell EJ
Environ Health Perspect; 2009 Nov; 117(11):1718-23. PubMed ID: 20049123
[TBL] [Abstract][Full Text] [Related]
13. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
Andrew AS; Karagas MR; Hamilton JW
Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548
[TBL] [Abstract][Full Text] [Related]
14. Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study.
Farzan SF; Chen Y; Rees JR; Zens MS; Karagas MR
Toxicol Appl Pharmacol; 2015 Sep; 287(2):93-97. PubMed ID: 26048586
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of bladder cancer and exposure to arsenic in Argentina.
Bates MN; Rey OA; Biggs ML; Hopenhayn C; Moore LE; Kalman D; Steinmaus C; Smith AH
Am J Epidemiol; 2004 Feb; 159(4):381-9. PubMed ID: 14769642
[TBL] [Abstract][Full Text] [Related]
16. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk.
Andrew AS; Mason RA; Kelsey KT; Schned AR; Marsit CJ; Nelson HH; Karagas MR
Toxicol Lett; 2009 May; 187(1):10-4. PubMed ID: 19429237
[TBL] [Abstract][Full Text] [Related]
17. Markers of low level arsenic exposure for evaluating human cancer risks in a US population.
Karagas MR; Le CX; Morris S; Blum J; Lu X; Spate V; Carey M; Stannard V; Klaue B; Tosteson TD
Int J Occup Med Environ Health; 2001; 14(2):171-5. PubMed ID: 11548067
[TBL] [Abstract][Full Text] [Related]
18. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations.
Karagas MR; Tosteson TD; Blum J; Klaue B; Weiss JE; Stannard V; Spate V; Morris JS
Am J Epidemiol; 2000 Jul; 152(1):84-90. PubMed ID: 10901333
[TBL] [Abstract][Full Text] [Related]
19. Estimating water supply arsenic levels in the New England Bladder Cancer Study.
Nuckols JR; Freeman LE; Lubin JH; Airola MS; Baris D; Ayotte JD; Taylor A; Paulu C; Karagas MR; Colt J; Ward MH; Huang AT; Bress W; Cherala S; Silverman DT; Cantor KP
Environ Health Perspect; 2011 Sep; 119(9):1279-85. PubMed ID: 21421449
[TBL] [Abstract][Full Text] [Related]
20. Geostatistical modelling of arsenic in drinking water wells and related toenail arsenic concentrations across Nova Scotia, Canada.
Dummer TJ; Yu ZM; Nauta L; Murimboh JD; Parker L
Sci Total Environ; 2015 Feb; 505():1248-58. PubMed ID: 24613511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
